To Evaluate the Safety and Efficacy of Preemptive Administration of Continuous Renal Replacement Therapy in Patients With Acute Liver Failure With Cerebral Edema -A Prospective Randomized Controlled Trial.

Institute of Liver and Biliary Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients with acute liver failure defined patients with jaundice which is complicated by encephalopathy and coagulopathy within 4 weeks of the onset of jaundice and without underlying chronic liver disease with documented cerebral edema on CT-scan and arterial ammonia >150 ug/dL.

•1.Age <18 or > 70 years
•2.Hepatocellular Carcinoma
•3.Active untreated Sepsis/DIC
•4.Hemodynamic instability requiring high dose of vasopressors
•5.Post-resection and malignancy related liver failure
•6.Coma of non-hepatic origin
•7.Patients with post renal obstructive AKI, AKI suspected due to glomerulonephritis, interstitial nephritis or vasculitis based on clinical history and urine analysis
•8.Patients already meeting emergency criteria for immediate initiation of dialysis at the time of randomization (serum potassium >6 meq/lt, metabolic acidosis ph <7.12, acute pulmonary edema, severe volume overload with hypoxemia non-responsive to diuretic treatment)
•9.Patients transferred from other hospitals who have already been on hemodialysis before their arrival in the intensive care unit
•10.Extremely moribund patients with an expected life expectancy of less than 24 hours
•11.Pregnancy related liver failure
•12.Patients with significant renal dysfunction meeting absolute criteria for initiation of dialysis
•13.Comorbidities associated with poor outcome (Extrahepatic neoplasia, severe cardiopulmonary disease defined by a New York Heart Association score >3, or oxygen/steroid-dependent chronic obstructive pulmonary disease)
•14.Patients being taken up for liver transplant
•15.Refusal to participate in the study.

发起方